Navigation Links
GenVec in Medical News

GenVec Announces Second Quarter 2009 Results Conference Call

...09 on Thursday, August 6, 2009 after market close. genvec will hold a conference call at 10:00 a.m. EDT on F... and click on "Webcasts and Data." About genvec GenVec, Inc. is a biopharmaceutical company de...l cancer, rectal cancer, and head and neck cancer. genvec also uses its proprietary adenovector technology t...

GenVec Receives Grant for Malaria Vaccine Program

...s GenVec. This funding supports the advancement of genvec technology by moving genvec into the antigen discovery phase of vaccine develo...ne development. Using the funding from this grant, genvec will be collaborating with the U.S. Naval Medical ...
GenVec in Medical Technology

TNFerade(TM) Phase III Data Presented at ASCO

... treatment of locally advanced pancreatic cancer. genvec is developing TNFerade for use in combination with...r the treatment of various cancers. About genvec GenVec, Inc. is a biopharmaceutical company...l cancer, rectal cancer, and head and neck cancer. genvec also uses its proprietary adenovector technology t...

GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting

...Presentations Will Highlight Research Conducted in genvec Malaria Vaccine Program GAITHERSBURG, Md....search conducted in this program, will be given by genvec scientists. Additional presentations, to be given by genvec collaborators, will provide updates on malaria vac...

GenVec Announces New Research at AACR on Selectivity and Mechanism of Action of TNF-Based Anti-Cancer Therapy

...III trial for locally advanced pancreatic cancer. genvec researchers presented a poster entitled, "Selectiv... the treatment of cancer," added Dr. King. About genvec GenVec, Inc. is a biopharmaceutical company deve...I studies are in progress in head and neck cancer. genvec also uses its proprietary adenovector technology t...

GenVec Presents Research on New Ad35 Adenovector at ARVO

...eins in the eye over a period of several months. genvec researchers compared the duration of expression in...ive and more convenient treatment for AMD. About genvec GenVec, Inc. is a biopharmaceutical company deve...I studies are in progress in head and neck cancer. genvec also uses its proprietary adenovector technology t...

GenVec Announces Update of Safety and Efficacy Data from Pivotal Phase II/III PACT Study of TNFerade at ASCO

...then follow the link to Webcasts and Data. About genvec GenVec, Inc. is a biopharmaceutical company deve...I studies are in progress in head and neck cancer. genvec also uses its proprietary adenovector technology t...nal and pandemic flu. Additional information about genvec is available at www.genvec.com and in the Company'...
GenVec in Biological News

Progress made in HIV vaccine development

...d colleagues from the National Institutes of Health IH Vaccine Research Center in Maryland, the Fred Hutchinson Cancer Research Center in Seattle, and genvec Incorporated tested two possible HIV vaccines with the hope of producing an immune response in healthy, uninfected adults. One was a plasmid DNA-base...
GenVec in Biological Technology

GenVec Reports Second Quarter 2009 Financial Results

....com/cgi-bin/prnh/20081205/DC50112LOGO ) genvec reported a net loss of $4.8 million ($0.05 per sha...ram as compared to the prior year periods. genvec ended the second quarter of 2009 with $12.6 millio...fficer. "In spite of the difficult economic times, genvec continues to make strides in its therapeutic and v...

GenVec Expands Contract Supporting Malaria Vaccine Program

..., head of GenVec's malaria program. About genvec GenVec, Inc. is a biopharmaceutical compa...l cancer, rectal cancer, and head and neck cancer. genvec also uses its proprietary adenovector technology t...rus (RSV), and HSV-2. Additional information about genvec is available at www.genvec.com and in the comp...

GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants

...clusive placement agent in this transaction. genvec will use proceeds from the offering for further de...he securities described above are being offered by genvec pursuant to a registration statement previously fi...r, solicitation, or sale is unlawful. About genvec GenVec, Inc. is a biopharmaceutical company de...
Other Tags
(Date:7/30/2014)... (PRWEB) July 30, 2014 The family ... bleeding has filed a Xarelto lawsuit ( http://www.xareltolawsuitcenter.com/ ... thinner, Bernstein Liebhard LLP reports. According to the complaint, ... District of Vermont on July 25th, the decedent had ... suffered an irreversible brain bleed that ultimately led to ...
(Date:7/30/2014)... Hawley, Pennsylvania (PRWEB) July 30, 2014 ... and have contributed over $8,500 to ensure its protection. ... Resort, presents a check to the Delaware Highlands Conservancy ... Partnership program. The small $2-per-stay donations add up fast, ... future of the Upper Delaware River Region. , The ...
(Date:7/30/2014)... July 30, 2014 (HealthDay News) -- Some obese people ... the reward centers in their brains when they see ... how this mutation triggers feelings of pleasure and gratification ... help improve strategies designed to prevent overeating, the scientists ... obese. Obesity is typically caused by a combination ...
(Date:7/30/2014)... KY (PRWEB) July 30, 2014 DRE ... pleased to announce the launch of its Medical ... online resource for medical professionals and equipment vendors. , ... shows and conventions in the United States and around ... the calendar, and that number is always growing. , ...
(Date:7/30/2014)... ... ... ... , UCLA researchers interviewed people ... published this week in the peer-reviewed journal Quality of Life Research , a UCLA team led by Dr. Brennan Spiegel interviewed ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Alleges Man’s Death from Uncontrollable Brain Bleeding Was Caused by Xarelto, Bernstein Liebhard LLP Reports 3Health News:Pocono Mountain Resort Guests Contribute Over $8500 to Protect Land in 6 Short Months 2Health News:Gene Mutation May Make Food More Tempting 2Health News:DRE Launches Online Interactive Medical Trade Show Calendar 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 2Health News:Diverticulitis patients reveal psychological, physical symptoms long after acute attacks 3
(Date:7/30/2014)... of Engineering recently received a $330,000 award from ... synthesis of organic nanorods." , According to ... and utilization of functional materials, devices, and systems ... in scaling up nanotechnology is the lack of ... one device. A research team led by Dr. ...
(Date:7/30/2014)... treatment has been shown to relieve patients, pain. ... transmission between the peripheral and central nervous systems, ... Radiation Medicine, Chinese Academy of Medical Sciences, China ... dorsal root ganglia (DRG) to provide relief for ... 14.8, 29.6 MBq) were implanted separately into the ...
(Date:7/30/2014)... 3,000 pieces is still in its infant stage. But ... of major significance. "Amazingly often, we are findingin addition ... that we found in Baltic amber," explained Bonn paleontologist ... comes from the Baltic Sea region, which is almost ... e.g., the coastal regions of Mecklenburg, Poland and Belarus. ...
Breaking Biology News(10 mins):NSF grant to Wayne State supports new concept for manufacturing nanoscale devices 2Chinese mosquitos on the Baltic Sea 2
Other Contents